Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn
OtherNEUROPHARMACOLOGY

Glycine Site Antagonists and Partial Agonists Inhibit N-Methyl-d-aspartate Receptor-Mediated [3H]Arachidonic Acid Release in Cerebellar Granule Cells

E. Viu, A. Zapata, J. L. Capdevila, L. H. Fossom, P. Skolnick and R. Trullas
Journal of Pharmacology and Experimental Therapeutics May 1998, 285 (2) 527-532;
E. Viu
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
A. Zapata
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
J. L. Capdevila
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
L. H. Fossom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
P. Skolnick
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
R. Trullas
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Abstract

Activation of N-methyl-d-aspartate (NMDA) receptors is known to produce arachidonic acid release, which has been implicated in excitotoxicity. Antagonists and partial agonists at the glycine site of the NMDA receptor, despite exhibiting functional differences in electrophysiological studies, inhibit glutamate-induced neurotoxicity and ischemia-induced neurodegeneration. The objective of this study was to investigate the effects of both glycine site antagonists and partial agonists on NMDA receptor-mediated [3H]arachidonic acid (AA) release evoked by glutamate, NMDA or a competitive inhibitor of the glutamate/aspartate uptake carrier. The [3H]AA release evoked by a maximally effective concentration of glutamate (100 μM) was blocked by the glycine site antagonists 7-chlorokynurenic acid (7-CKYN) and 5,7- dichlorokynurenic acid (5,7-DCKYN) and by a low intrinsic efficacy glycine partial agonist (+)-1-hydroxy-3-aminopyrrolid-2-one [(+)-HA-966]. 1-Aminocyclopropanecarboxylic acid (ACPC), a high intrinsic efficacy glycine partial agonist, did not modify [3H]AA release evoked by 100 μM glutamate. However, ACPC blocked (in a glycine reversible manner) the [3H]AA release induced by NMDA (100 μM) with an IC50 of 131 ± 2 μM. Furthermore,l-trans-pyrrolidine-2,4-dicarboxylate (PDC), a competitive inhibitor of the glutamate transporter, also released [3H]AA (Emax and EC50 of 127 ± 4% and 30 ± 1 μM, respectively). ACPC, 7-CKYN and (±)-2-amino-7-phosphonoheptanoic acid (AP-7), a competitive NMDA receptor antagonist, inhibited [3H]AA release evoked by PDC. These results demonstrate that both glycine site antagonists and partial agonists can inhibit NMDA receptor-mediated [3H]AA release in cerebellar granule cells, an action consistent with the neuroprotective effects of these compounds.

Footnotes

  • Send reprint requests to: Ramon Trullas, Ph.D., Unitat de Neurobiologia, IIBB/C.S.I.C., Jordi Girona 18–26, 08034 Barcelona, Spain. E-mail: rtonbi{at}cid.csic.es

  • ↵1 This work was supported by a grant from Dirección General de Investigación Cientı́fica y Técnica, Ministry of Education of Spain, DGICYT, PB94–0017 to R.T.

  • ↵2 E.V. was supported by a predoctoral fellowship from Direcció General D’Universitats/CIRIT. Generalitat de Catalunya.

  • ↵3 A.Z. is a Severo Ochoa Fellow from Ferrer International Foundation.

  • Abbreviations:
    AA
    arachidonic acid
    ACPC
    1-aminocyclopropanecarboxylic acid
    (±)-AP-5
    2-amino-5-phosphonopentanoic acid
    (±)-AP-7
    2-amino-7-phosphonoheptanoic acid
    ASP
    aspartate
    BSA
    bovine serum albumin
    7-CKYN
    7-chlorokynurenic acid
    5
    7-DCKYN, 5,7-dichlorokynurenic acid
    GLU
    glutamate
    GLY
    glycine
    (+)-HA-966
    1-hydroxy-3-aminopyrrolid-2-one
    HPLC
    high-pressure liquid chromatography
    LH-BSA
    Locke-HEPES buffer with fatty acid-free bovine serum albumin
    MK-801
    5-methyl-10,11-dihydro-5H-dibenzo(a,d)cyclohept- 5,10-imine hydrogen, dizocilpine maleate
    NMDA
    N-methyl-d-aspartate
    PDC
    l-trans-pyrrolidine-2,4-dicarboxylic acid
    • Received October 9, 1997.
    • Accepted January 26, 1998.
  • The American Society for Pharmacology and Experimental Therapeutics
View Full Text

JPET articles become freely available 12 months after publication, and remain freely available for 5 years. 

Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page. 

 

  • Click here for information on institutional subscriptions.
  • Click here for information on individual ASPET membership.

 

Log in using your username and password

Forgot your user name or password?

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.
PreviousNext
Back to top

In this issue

Journal of Pharmacology and Experimental Therapeutics
Vol. 285, Issue 2
1 May 1998
  • Table of Contents
  • Index by author
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Journal of Pharmacology and Experimental Therapeutics article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Glycine Site Antagonists and Partial Agonists Inhibit N-Methyl-d-aspartate Receptor-Mediated [3H]Arachidonic Acid Release in Cerebellar Granule Cells
(Your Name) has forwarded a page to you from Journal of Pharmacology and Experimental Therapeutics
(Your Name) thought you would be interested in this article in Journal of Pharmacology and Experimental Therapeutics.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
OtherNEUROPHARMACOLOGY

Glycine Site Antagonists and Partial Agonists Inhibit N-Methyl-d-aspartate Receptor-Mediated [3H]Arachidonic Acid Release in Cerebellar Granule Cells

E. Viu, A. Zapata, J. L. Capdevila, L. H. Fossom, P. Skolnick and R. Trullas
Journal of Pharmacology and Experimental Therapeutics May 1, 1998, 285 (2) 527-532;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
OtherNEUROPHARMACOLOGY

Glycine Site Antagonists and Partial Agonists Inhibit N-Methyl-d-aspartate Receptor-Mediated [3H]Arachidonic Acid Release in Cerebellar Granule Cells

E. Viu, A. Zapata, J. L. Capdevila, L. H. Fossom, P. Skolnick and R. Trullas
Journal of Pharmacology and Experimental Therapeutics May 1, 1998, 285 (2) 527-532;
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Experimental Procedures
    • Results
    • Discussion
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Disease-Modifying Effects of Neurosteroids in Post-SE Models
  • Lacosamide and Rufinamide Against SE
  • A pediatric rat model of OP-induced status epilepticus
Show more Neuropharmacology

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics